查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1600662

避孕药市场：按产品、性别、方法和分布划分 - 全球预测 2025-2030

Contraceptive Market by Product (Devices, Drugs), Gender (Female Contraceptive, Male Contraceptive), Method, Distribution - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年避孕药市场规模为484.3亿美元，预计2024年将达到548.7亿美元，复合年增长率为13.82%，2030年将达到1198.9亿美元。

避孕市场包括各种旨在预防怀孕、管理生殖健康和对抗性性行为感染的产品和服务。该系列包括荷尔蒙避孕法（如避孕药和注射避孕药）、屏障避孕法（如保险套和隔膜）以及新技术（如子宫内避孕器 (IUD)、避孕植入和贴片）。世界对生殖健康权利、人口控制以及赋予妇女对计划生育做出明智选择的权利的日益关注，推动了对此类产品的需求。避孕药具用途广泛，可满足临时和长期需求，最终用途范围从个人消费者到医疗保健提供者和有组织的分销管道。

主要市场统计
基准年[2023] 484.3亿美元
预测年份 [2024] 548.7亿美元
预测年份 [2030] 1198.9亿美元
复合年增长率（%） 13.82%

影响避孕市场的主要成长要素包括人们对生殖健康措施的认识和接受程度的提高、政府对计划生育的宣传活动以及导致更有效和方便的避孕方法的技术进步。潜在的机会存在于扩大避孕需求未被满足的发展中地区的获取，以及满足已开发国家对更个性化且无副作用的选择的需求。与政府和非政府组织的策略伙伴关係可以扩大市场范围和渗透率。然而，由于社会和宗教阻力、潜在副作用、使用误解以及区域监管挑战，市场成长面临限制。

成熟的研究创新领域包括开发男性避孕药、减少女性副作用的非荷尔蒙选择，以及提供个人化避孕建议的数位健康解决方案。避孕药具市场是动态的，对文化、社会和经济因素高度敏感。对市场行为的洞察表明，消费者的偏好正在转向便利性、微创性和长期可靠性，这为投资这些创新的公司展现了巨大潜力。策略建议包括投资尖端解决方案的研发、加强消费者教育以及调整行销策略以克服文化障碍和误解。

市场动态：揭示快速发展的避孕市场的关键市场洞察

供需的动态交互作用正在改变避孕药具市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 对性健康和计划生育的认识不断提高
    • 政府支持的鼓励使用和提供避孕药的倡议
  • 市场限制因素
    • 避孕产品对健康的不良影响
  • 市场机会
    • 透过广泛的研究和开发引入负担得起的避孕方法
    • 透过线上通路提供避孕药具
  • 市场挑战
    • 有关避孕药具使用的社会关注和产品行销问题

波特五力：驾驭避孕市场的策略工具

波特的五力框架是了解避孕市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解避孕药市场的外部影响

外部宏观环境因素对避孕药具市场的表现动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解避孕药具市场的竞争格局

对避孕药市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵避孕药具市场供应商绩效评估

FPNV定位矩阵是评估避孕药具市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。四个象限清楚且准确地划分供应商，帮助使用者辨识最能满足其策略目标的合作伙伴和解决方案。

本报告提供了涵盖关键重点领域的全面市场分析：

1. 市场渗透率：对当前市场环境的详细回顾，包括行业主要企业的大量资料。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 提高对性健康和计划生育的认识
      • 政府支持措施鼓励避孕药的使用和提供
    • 抑制因素
      • 避孕产品对健康的不良影响
    • 机会
      • 透过广泛的研究和开发介绍经济实惠的避孕方法
      • 透过线上通路提供避孕器
    • 任务
      • 有关避孕药具使用的社会关注和产品行销问题
  • 市场区隔分析
    • 产品：由于易于使用和非侵入性，避孕药物的高趋势
    • 性别：由于产品种类繁多，女性用避孕器的采用率显着增加。
    • 方法：屏障避孕法在性行为过程中提供物理和化学屏障，越来越受欢迎。
    • 分销管道：网路药局的24/7 服务增强了产品分销。
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 避孕药市场：副产品

  • 装置
    • 保险套
    • 隔膜
    • 子宫内避孕器
      • 含铜子宫内避孕器
      • 荷尔蒙子宫内避孕器
    • 皮下植入
    • 避孕环
  • 药物
    • 注射
    • 口服锭剂
    • 经皮避孕贴剂

第七章 避孕药市场性别

  • 女性避孕药
  • 男性避孕药

第八章避孕药市场：依方法分类

  • 障碍
  • 和谐的

第九章 避孕药具市场经销商

  • 连锁药房
  • 诊所
  • 政府网络
  • 医院药房
  • 独立药房
  • 网路平台

第十章美洲避孕药市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太避孕市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲、中东和非洲避孕市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 列治文生物科技公司斥资1亿美元收购避孕药业务
    • 英国开始首次试验无荷尔蒙男性避孕药
    • Aditxt 以 1 亿美元收购 Phexxi 避孕凝胶製造商 Evofem
    • Dare Biosciences 开始无激素三期避孕试验
    • Lupin 在美国推出 Turcoz（炔诺孕酮和炔雌醇）片剂 USP
    • 拜耳和 Crossbay Medical 开发新型子宫内系统插入器
    • Xiromed LLC 宣布在美国推出 EnilloRing
    • 拜耳将在芬兰建造新的 2.672 亿美元生产设施，以促进全球采用现代避孕方法
    • NIH 中心津贴加强男性研究
    • 盖兹基金会、儿童投资基金基金会、辉瑞和 BD 扩大合作伙伴关係，以扩大女性获得注射的机会
    • Perrigo与美国FDA宣布核准OTC每日口服药物「Opil」避孕药
    • FDA核准首个非处方笺口服避孕药
    • Sirona 收购印度首个纯素保险套品牌 Blue

公司名单

  • Abbvie Inc.
  • Acme Generics Pvt. Ltd.
  • Afaxys, Inc.
  • Agile Therapeutics, Inc.
  • Amneal Pharmaceuticals LLC
  • ASKA Pharmaceutical Co., Ltd.
  • Aurobindo Pharma Limited
  • Bayer AG
  • Church & Dwight Co., Inc.
  • HLL Lifecare Limited
  • Insud Pharma, SL
  • Johnson & Johnson Services, Inc.
  • Lupin Limited
  • Mayne Pharma Group Limited
  • Merck & Co., Inc.
  • Mithra Pharmaceuticals SA
  • Okamoto Industries, Inc.
  • Organon & Co.
  • Perrigo Company plc
  • Pfizer Inc.
  • Piramal Pharma Ltd.
  • Reckitt Benckiser Group plc
  • RITEX GMBH
  • Sanofi SA
  • Say It With A Condom, LLC.
  • Syzygy Healthcare Solutions LLC
  • Teva Pharmaceutical Industries Ltd.
  • TherapeuticsMD, Inc.
  • TTK Healthcare Limited
  • Veru Inc.
  • Viatris Inc.
Product Code: MRR-4316E4E895C4

The Contraceptive Market was valued at USD 48.43 billion in 2023, expected to reach USD 54.87 billion in 2024, and is projected to grow at a CAGR of 13.82%, to USD 119.89 billion by 2030.

The contraceptive market encompasses a range of products and services aimed at preventing pregnancy, managing reproductive health, and addressing sexually transmitted infections. Its scope includes hormonal methods like pills and injectable contraceptives, barrier methods such as condoms and diaphragms, intrauterine devices (IUDs), and emerging technologies like contraceptive implants and patches. The necessity for such products is driven by the increasing global focus on reproductive health rights, population control, and the empowerment of women to make informed choices regarding family planning. The application of contraceptives is widespread, catering to both temporary and long-term needs of users, with end-use scopes stretching from individual consumers to healthcare providers and institutional distribution channels.

KEY MARKET STATISTICS
Base Year [2023] USD 48.43 billion
Estimated Year [2024] USD 54.87 billion
Forecast Year [2030] USD 119.89 billion
CAGR (%) 13.82%

Key growth factors influencing the contraceptive market include the rising awareness and acceptance of reproductive health measures, supportive governmental campaigns for family planning, and technological advancements leading to more efficient and convenient contraceptive methods. There are potential opportunities in expanding access in developing regions where unmet needs for contraceptives are high, as well as addressing the demand in developed countries for more personalized and side-effect-free options. Strategic partnerships with governmental and non-governmental organizations can enhance market reach and penetration. However, market growth faces limitations from societal and religious resistances, potential side effects and misconceptions about contraceptive use, and regulatory challenges in different regions.

Innovative areas ripe for research include the development of male contraceptives, non-hormonal options that reduce side effects for women, and digital health solutions that offer personalized contraceptive advice. The contraceptive market is dynamic and highly sensitive to cultural, social, and economic factors. Insights into market behavior suggest a consumer preference shift towards convenience, minimal invasiveness, and long-term reliability, indicating significant potential for companies investing in these innovations. Strategic recommendations include investing in R&D for cutting-edge solutions, enhancing consumer education, and tailoring marketing strategies to overcome cultural barriers and misconceptions.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Contraceptive Market

The Contraceptive Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increased awareness regarding sexual health and family planning
    • Supportive government initiatives to encourage use and provision of contraceptive pills
  • Market Restraints
    • Adverse health impacts of contraceptive products
  • Market Opportunities
    • Introduction of affordable contraceptive methods with extensive R&D
    • Availability of contraceptives through online distribution channels
  • Market Challenges
    • Social concerns regarding contraceptive usage and issues with product marketing

Porter's Five Forces: A Strategic Tool for Navigating the Contraceptive Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Contraceptive Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Contraceptive Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Contraceptive Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Contraceptive Market

A detailed market share analysis in the Contraceptive Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Contraceptive Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Contraceptive Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Contraceptive Market, highlighting leading vendors and their innovative profiles. These include Abbvie Inc., Acme Generics Pvt. Ltd., Afaxys, Inc., Agile Therapeutics, Inc., Amneal Pharmaceuticals LLC, ASKA Pharmaceutical Co., Ltd., Aurobindo Pharma Limited, Bayer AG, Church & Dwight Co., Inc., HLL Lifecare Limited, Insud Pharma, S.L., Johnson & Johnson Services, Inc., Lupin Limited, Mayne Pharma Group Limited, Merck & Co., Inc., Mithra Pharmaceuticals S.A., Okamoto Industries, Inc., Organon & Co., Perrigo Company plc, Pfizer Inc., Piramal Pharma Ltd., Reckitt Benckiser Group plc, RITEX GMBH, Sanofi S.A., Say It With A Condom, LLC., Syzygy Healthcare Solutions LLC, Teva Pharmaceutical Industries Ltd., TherapeuticsMD, Inc., TTK Healthcare Limited, Veru Inc., and Viatris Inc..

Market Segmentation & Coverage

This research report categorizes the Contraceptive Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Devices and Drugs. The Devices is further studied across Condoms, Diaphragm, IUDs, Subdermal Implants, and Vaginal Rings. The IUDs is further studied across Copper IUDs and Hormonal IUDs. The Drugs is further studied across Injectables, Oral Contraceptive Pills, and Transdermal Contraceptive Patch.
  • Based on Gender, market is studied across Female Contraceptive and Male Contraceptive.
  • Based on Method, market is studied across Barrier and Harmonal.
  • Based on Distribution, market is studied across Chain Pharmacy, Clinics, Government Network, Hospital Pharmacy, Independent Pharmacy, and Online Platform.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increased awareness regarding sexual health and family planning
      • 5.1.1.2. Supportive government initiatives to encourage use and provision of contraceptive pills
    • 5.1.2. Restraints
      • 5.1.2.1. Adverse health impacts of contraceptive products
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of affordable contraceptive methods with extensive R&D
      • 5.1.3.2. Availability of contraceptives through online distribution channels
    • 5.1.4. Challenges
      • 5.1.4.1. Social concerns regarding contraceptive usage and issues with product marketing
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: High inclination toward contraceptive drugs due to their ease of use and non-invasiveness
    • 5.2.2. Gender: Significant adoption of female contraceptives due to availability of a wide range of products
    • 5.2.3. Method: Rising preference for barrier methods of contraception that provide a physical and chemical barrier during sexual activities
    • 5.2.4. Distribution Channel: Enhanced product distribution through online pharmacies due to their 24/7 services
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Contraceptive Market, by Product

  • 6.1. Introduction
  • 6.2. Devices
    • 6.2.1. Condoms
    • 6.2.2. Diaphragm
    • 6.2.3. IUDs
      • 6.2.3.1. Copper IUDs
      • 6.2.3.2. Hormonal IUDs
    • 6.2.4. Subdermal Implants
    • 6.2.5. Vaginal Rings
  • 6.3. Drugs
    • 6.3.1. Injectables
    • 6.3.2. Oral Contraceptive Pills
    • 6.3.3. Transdermal Contraceptive Patch

7. Contraceptive Market, by Gender

  • 7.1. Introduction
  • 7.2. Female Contraceptive
  • 7.3. Male Contraceptive

8. Contraceptive Market, by Method

  • 8.1. Introduction
  • 8.2. Barrier
  • 8.3. Harmonal

9. Contraceptive Market, by Distribution

  • 9.1. Introduction
  • 9.2. Chain Pharmacy
  • 9.3. Clinics
  • 9.4. Government Network
  • 9.5. Hospital Pharmacy
  • 9.6. Independent Pharmacy
  • 9.7. Online Platform

10. Americas Contraceptive Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Contraceptive Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Contraceptive Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Richmond Biotech Company to buy Contraceptive biz for USD 100 Million
    • 13.3.2. UK Launches First Trial of Hormone-free Male Birth Control pill
    • 13.3.3. Aditxt Acquires Phexxi Contraceptive Gel-Maker Evofem for USD 100 million
    • 13.3.4. Dare Bioscience Launches Phase III Hormone-free Contraceptive Trial
    • 13.3.5. Lupin Launches Turqoz (Norgestrel and Ethinyl Estradiol) Tablets USP in the United States
    • 13.3.6. Bayer and CrossBay Medical to Develop Novel Intrauterine System Inserter
    • 13.3.7. Xiromed LLC Announces Launch of EnilloRing in the United States
    • 13.3.8. Bayer Invests in USD 267.2 Million new Production Facility in Finland to Accelerate Global Access to Modern Contraception
    • 13.3.9. NIH Center Grant Bolsters Male Contraceptive Research
    • 13.3.10. Gates Foundation, Children's Investment Fund Foundation, Pfizer and BD Company Expand Partnership for Greater Access to Injectable Contraceptive for Women
    • 13.3.11. Perrigo Announces U.S. FDA Approval for Opill OTC Daily Oral Contraceptive
    • 13.3.12. FDA Approves First Nonprescription Daily Oral Contraceptive
    • 13.3.13. Sirona Acquires India's First Vegan Condom Brand Bleu

Companies Mentioned

  • 1. Abbvie Inc.
  • 2. Acme Generics Pvt. Ltd.
  • 3. Afaxys, Inc.
  • 4. Agile Therapeutics, Inc.
  • 5. Amneal Pharmaceuticals LLC
  • 6. ASKA Pharmaceutical Co., Ltd.
  • 7. Aurobindo Pharma Limited
  • 8. Bayer AG
  • 9. Church & Dwight Co., Inc.
  • 10. HLL Lifecare Limited
  • 11. Insud Pharma, S.L.
  • 12. Johnson & Johnson Services, Inc.
  • 13. Lupin Limited
  • 14. Mayne Pharma Group Limited
  • 15. Merck & Co., Inc.
  • 16. Mithra Pharmaceuticals S.A.
  • 17. Okamoto Industries, Inc.
  • 18. Organon & Co.
  • 19. Perrigo Company plc
  • 20. Pfizer Inc.
  • 21. Piramal Pharma Ltd.
  • 22. Reckitt Benckiser Group plc
  • 23. RITEX GMBH
  • 24. Sanofi S.A.
  • 25. Say It With A Condom, LLC.
  • 26. Syzygy Healthcare Solutions LLC
  • 27. Teva Pharmaceutical Industries Ltd.
  • 28. TherapeuticsMD, Inc.
  • 29. TTK Healthcare Limited
  • 30. Veru Inc.
  • 31. Viatris Inc.

LIST OF FIGURES

  • FIGURE 1. CONTRACEPTIVE MARKET RESEARCH PROCESS
  • FIGURE 2. CONTRACEPTIVE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CONTRACEPTIVE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CONTRACEPTIVE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CONTRACEPTIVE MARKET SIZE, BY GENDER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CONTRACEPTIVE MARKET SIZE, BY GENDER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CONTRACEPTIVE MARKET SIZE, BY METHOD, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CONTRACEPTIVE MARKET SIZE, BY METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. CONTRACEPTIVE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. CONTRACEPTIVE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CONTRACEPTIVE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CONTRACEPTIVE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CONTRACEPTIVE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CONTRACEPTIVE MARKET DYNAMICS
  • TABLE 7. GLOBAL CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CONTRACEPTIVE MARKET SIZE, BY CONDOMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DIAPHRAGM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CONTRACEPTIVE MARKET SIZE, BY IUDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CONTRACEPTIVE MARKET SIZE, BY COPPER IUDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CONTRACEPTIVE MARKET SIZE, BY HORMONAL IUDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CONTRACEPTIVE MARKET SIZE, BY SUBDERMAL IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CONTRACEPTIVE MARKET SIZE, BY VAGINAL RINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CONTRACEPTIVE MARKET SIZE, BY INJECTABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CONTRACEPTIVE MARKET SIZE, BY ORAL CONTRACEPTIVE PILLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CONTRACEPTIVE MARKET SIZE, BY TRANSDERMAL CONTRACEPTIVE PATCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CONTRACEPTIVE MARKET SIZE, BY FEMALE CONTRACEPTIVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CONTRACEPTIVE MARKET SIZE, BY MALE CONTRACEPTIVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CONTRACEPTIVE MARKET SIZE, BY BARRIER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CONTRACEPTIVE MARKET SIZE, BY HARMONAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL CONTRACEPTIVE MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL CONTRACEPTIVE MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL CONTRACEPTIVE MARKET SIZE, BY GOVERNMENT NETWORK, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL CONTRACEPTIVE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL CONTRACEPTIVE MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL CONTRACEPTIVE MARKET SIZE, BY ONLINE PLATFORM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 64. CANADA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 70. MEXICO CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 71. MEXICO CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 78. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 79. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 92. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 93. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 94. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 95. CHINA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. CHINA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 98. CHINA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 99. CHINA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 100. CHINA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 101. CHINA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 102. INDIA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. INDIA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 104. INDIA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 105. INDIA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 106. INDIA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 107. INDIA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 108. INDIA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 109. INDONESIA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. INDONESIA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 111. INDONESIA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 112. INDONESIA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 113. INDONESIA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 114. INDONESIA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 115. INDONESIA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 116. JAPAN CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. JAPAN CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 118. JAPAN CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 119. JAPAN CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 120. JAPAN CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 121. JAPAN CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 122. JAPAN CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 123. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 125. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 126. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 127. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 128. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 129. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 130. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 132. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 133. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 134. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 135. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 136. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 137. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 139. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 140. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 141. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 142. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 143. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 144. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 146. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 147. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 148. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 149. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 150. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 151. TAIWAN CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. TAIWAN CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 153. TAIWAN CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 154. TAIWAN CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 155. TAIWAN CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 156. TAIWAN CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 157. TAIWAN CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 158. THAILAND CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 159. THAILAND CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 160. THAILAND CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 161. THAILAND CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 162. THAILAND CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 163. THAILAND CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 164. THAILAND CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 165. VIETNAM CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 166. VIETNAM CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 167. VIETNAM CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 168. VIETNAM CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 169. VIETNAM CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 170. VIETNAM CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 171. VIETNAM CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 180. DENMARK CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. DENMARK CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 182. DENMARK CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 183. DENMARK CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 184. DENMARK CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 185. DENMARK CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 186. DENMARK CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 187. EGYPT CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 188. EGYPT CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 189. EGYPT CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 190. EGYPT CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 191. EGYPT CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 192. EGYPT CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 193. EGYPT CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 194. FINLAND CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 195. FINLAND CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 196. FINLAND CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 197. FINLAND CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 198. FINLAND CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 199. FINLAND CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 200. FINLAND CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 201. FRANCE CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 202. FRANCE CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 203. FRANCE CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 204. FRANCE CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 205. FRANCE CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 206. FRANCE CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 207. FRANCE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 208. GERMANY CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 209. GERMANY CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 210. GERMANY CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 211. GERMANY CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 212. GERMANY CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 213. GERMANY CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 214. GERMANY CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 215. ISRAEL CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 216. ISRAEL CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 217. ISRAEL CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 218. ISRAEL CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 219. ISRAEL CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 220. ISRAEL CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 221. ISRAEL CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 222. ITALY CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 223. ITALY CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 224. ITALY CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 225. ITALY CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 226. ITALY CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 227. ITALY CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 228. ITALY CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 229. NETHERLANDS CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 230. NETHERLANDS CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 231. NETHERLANDS CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 232. NETHERLANDS CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 233. NETHERLANDS CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 234. NETHERLANDS CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 235. NETHERLANDS CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 236. NIGERIA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 237. NIGERIA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 238. NIGERIA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 239. NIGERIA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 240. NIGERIA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 241. NIGERIA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 242. NIGERIA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 243. NORWAY CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 244. NORWAY CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 245. NORWAY CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 246. NORWAY CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 247. NORWAY CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 248. NORWAY CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 249. NORWAY CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 250. POLAND CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 251. POLAND CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 252. POLAND CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 253. POLAND CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 254. POLAND CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 255. POLAND CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 256. POLAND CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 257. QATAR CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 258. QATAR CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 259. QATAR CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 260. QATAR CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 261. QATAR CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 262. QATAR CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 263. QATAR CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 264. RUSSIA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 265. RUSSIA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 266. RUSSIA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 267. RUSSIA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 268. RUSSIA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 269. RUSSIA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 270. RUSSIA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 271. SAUDI ARABIA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 272. SAUDI ARABIA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 273. SAUDI ARABIA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 274. SAUDI ARABIA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 275. SAUDI ARABIA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 276. SAUDI ARABIA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 277. SAUDI ARABIA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 278. SOUTH AFRICA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 279. SOUTH AFRICA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 280. SOUTH AFRICA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 281. SOUTH AFRICA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 282. SOUTH AFRICA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 283. SOUTH AFRICA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 284. SOUTH AFRICA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 285. SPAIN CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 286. SPAIN CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 287. SPAIN CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 288. SPAIN CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 289. SPAIN CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 290. SPAIN CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 291. SPAIN CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 292. SWEDEN CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 293. SWEDEN CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 294. SWEDEN CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 295. SWEDEN CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 296. SWEDEN CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 297. SWEDEN CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 298. SWEDEN CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 299. SWITZERLAND CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 300. SWITZERLAND CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 301. SWITZERLAND CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 302. SWITZERLAND CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 303. SWITZERLAND CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 304. SWITZERLAND CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 305. SWITZERLAND CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 306. TURKEY CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 307. TURKEY CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 308. TURKEY CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 309. TURKEY CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 310. TURKEY CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 311. TURKEY CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 312. TURKEY CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 313. UNITED ARAB EMIRATES CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 314. UNITED ARAB EMIRATES CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 315. UNITED ARAB EMIRATES CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 316. UNITED ARAB EMIRATES CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 317. UNITED ARAB EMIRATES CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 318. UNITED ARAB EMIRATES CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 319. UNITED ARAB EMIRATES CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 320. UNITED KINGDOM CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 321. UNITED KINGDOM CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 322. UNITED KINGDOM CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 323. UNITED KINGDOM CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 324. UNITED KINGDOM CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 325. UNITED KINGDOM CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 326. UNITED KINGDOM CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 327. CONTRACEPTIVE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 328. CONTRACEPTIVE MARKET, FPNV POSITIONING MATRIX, 2023